Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment I (7th of 10 Lectures on Toxicologic Epidemiology)

Slides:



Advertisements
Similar presentations
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Advertisements

Defining The Environment & Environmental Health 1.
Risk Assessment.
Epidemiologic study designs
Using Pesticides Safely.  RST.11 ‐ 12.1 Cite specific textual evidence to support analysis of science and technical texts, attending to important distinctions.
International Atomic Energy Agency ASSESSMENT OF OCCUPATIONAL EXPOSURE DUE TO INTAKES OF RADIONUCLIDES Interpretation of Measurement Results.
Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment II (8th of 10 Lectures on Toxicologic Epidemiology)
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
Exposure Assessment Thanks to Marc Rigas, PhD for an earlier version of this lecture Much of the materials is drawn from Paustenbach, DJ. (2000) The practice.
1 / 24 CS 425/625 Software Engineering Software Evolution Based on Chapter 21 of the textbook [SE-8] Ian Sommerville, Software Engineering, 8 th Ed., Addison-Wesley,
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 5 The Actions of Drugs.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
Environmental Health XIV. Standards and Monitoring Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental.
Risk Assessment.
Copyright 2002 Marc Rigas Issues in Exposure Assessment Marc L. Rigas, Ph.D. National Exposure Research Laboratory, U.S. Environmental Protection Agency.
Michael H. Dong MPH, DrPA, PhD  readings Toxicology and Risk Assessment (3rd of 10 Lectures on Toxicologic Epidemiology)
CE Introduction to Environmental Engineering and Science Readings for This Class: Chapter 4 O hio N orthern U niversity Introduction Chemistry,
Michael H. Dong MPH, DrPA, PhD readings Toxicologic Epidemiology (10th of 10 Lectures on Toxicologic Epidemiology)
NORA Exposure Assessment Methods Team Whitepaper Research Needs and Priorities Beth Donovan Reh National Institute for Occupational Safety and Health (NIOSH)
Caring for Children With Special Medical Conditions
Supercourse Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD.
Lecture #3 Hazards and their effects. Epidemiology = The study of the distribution and causes of disease and injuries in human populations. – Epidemiologists.
Michael H. Dong MPH, DrPA, PhD readings Epidemiologic Side of Toxicology (6th of 10 Lectures on Toxicologic Epidemiology)
Arsenic in the Soils, USGS.
CS 425/625 Software Engineering Legacy Systems
Approaches for Evaluating the Relevance of Multiroute Exposures in Establishing Guideline Values for Drinking Water Contaminants Kannan Krishnan, Université.
Copyright © 2002 University of Maryland School of Nursing. All rights reserved. Comparison of Pharmacology and Toxicology This material was developed at.
Bioavailability Dr Mohammad Issa.
Intervention for Chronic and Emergency Exposure Situations Assessment and Response during Radiological Emergency Dose Assessment Overview Lecture IAEA.
The science that deals with the recognition, evaluation and control of hazards in workplaces in order to prevent illness among employees. ?
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
Health Risk from Consuming POC-Contaminated Fish: Part II. Risk Analysis and Prevention Strategies Michael H. Dong, MPH, DrPA, PhD October, 2007 Readings.
Determining Risks to Background Arsenic Using a Margin – of – Exposure Approach Presentation at Society of Risk Analysis, New England Chapter Barbara D.
Pollution and Human Health
Biopharmaceutics refers to the relationship of the:
1 Chemical and Biological Agents. 2 Introduction  Most occupational diseases such as asbestosis, silicosis, various types of dermatitis, spills, and.
Risk Assessment.
Public Health and Risk Assessment (2nd of 10 Lectures on Toxicologic Epidemiology) Michael H. Dong MPH, DrPA, PhD  readings.
Environmental Health and Toxicology
PESTICIDES AWARENESS TRAINING.
Michael H. Dong MPH, DrPA, PhD  readings Epidemiology and Risk Assessment (4th of 10 Lectures on Toxicologic Epidemiology)
EHS 507 Potential dose: the amount of chemical that is ingested or inhaled, or the amount of chemical contained in material applied to skin. Applied dose:
An Overview of the Objectives, Approach, and Components of ComET™ Mr. Paul Price The LifeLine Group All slides and material Copyright protected.
Instructor Resource Chapter 15 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
Who’s Risk Is It? Risk-Based Decision-Making in Indian Country Ms. Marilyn Null Deputy for Community-Based Programs U.S. Air Force.
ASSESSMENT OF OCCUPATIONAL EXPOSURE DUE TO INTAKE OF RADIONUCLIDES
RISK DUE TO AIR POLLUTANTS
PHT 415 BASIC PHARMACOKINETICS
Toxicology and Epidemiology (1st of 10 Lectures on Toxicologic Epidemiology) Michael H. Dong MPH, DrPA, PhD  readings.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
An Introductory Lecture to Environmental Epidemiology Part 4. Some Issues in Exposure Assessment Mark S. Goldberg INRS-Institut Armand-Frappier, University.
Chain of infection 1 Prof. Hamed Adetunji. Course Overview At the end of this lecture and the activities that follow, student will be able to: List the.
Key Concepts on Health Risk Assessment of Chemical Mixtures.
이 장 우. 1. Introduction  Bisphenol A is a high production volume chemical -Annual production of over six billion pounds -polycarbonate plastics.
Michael H. Dong MPH, DrPA, PhD readings Characterization of Health Risk (9th of 10 Lectures on Toxicologic Epidemiology)
©2012 Cengage Learning. All Rights Reserved. Chapter 4 Common Chronic Medical Conditions Affecting Children’s Health.
Risk CHARACTERIZATION
IAEA International Atomic Energy Agency Lecture 5 – Internal dose assessment and interpretation of measurement results Postgraduate Educational Course.
1 Role of Public Health Nursing in Environmental Health Presented by Marita Santos, RN, MSN Stella Fogleman, RN, MSN/MPH Los Angeles County Department.
Interest Approach Begin a discussion with your students about how you believe in having a law that requires everyone in a car to wear a seat belt. Encourage.
Lecture 4: Risk Analysis
Biologic Monitoring A. H. Mehrparvar, MD
General Toxicology General Considerations in Toxicology Lec
Biopharmaceutics Dr Mohammad Issa Saleh.
Clinical Pharmacokinetics
이 장 우.
Arsenic in the Soils, USGS
Introduction to Internal Dosimetry
Summing up and next steps
Introduction to Risk Assessment
Presentation transcript:

Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment I (7th of 10 Lectures on Toxicologic Epidemiology)

Taken in the early ’90s, when desktop computers were still a luxury.

Learning Objectives Learn the definition, the purpose, and the function of human exposure assessment (HEA). Appreciate the dynamics and complexity of HEA. Study the basic techniques, the advantages, and the limitations of human biological monitoring.

Performance Objectives Able to define the key concepts and terms used throughout this lecture. To outline the advantages and limitations of human biological monitoring (HBM) in human exposure assessment. To explain why HBM cannot be performed for every agent or for every exposure scenario available.

Key Terms/Concepts Exposure assessment and exposure measurement are different processes. Exposure - the contact between an agent and a human’s outer boundary (the skin, the lung, etc.). Applied dose - the amount of the agent present at these outer boundaries. Internal dose - the total amount of the agent available or present in the body.

Toxicologists in Human Exposure Assessment HEA in toxicology textbooks is incomplete and fragmented, often as part of a chapter on risk assessment. Toxicologists are better trained to use animal models and bioassays. They have been working indirectly with those involved in HEA.

Epidemiologists in Human Exposure Assessment HEA is covered more fully in epidemiology textbooks, in part because it is performed mainly for environmental contaminants. HEA is not appealing to those epidemiologists who are more involved in etiology testing.

Simplified Complexity of Human Exposure Assessment (click for larger image)click for larger image Air Water Food Soil Surface Dietary Ingestion Dermal Inhalation

Case 1. Child Exposure at the Playground InhalationDietary IngestionDermal

Case 2. Swimmer Exposure at the Pool InhalationDietary IngestionDermal

Case 3. Harvester Exposure at the Field InhalationDietary IngestionDermal

Case 4. Applicator Exposure at the Field InhalationDietary IngestionDermal

Approaches to Human Exposure Assessment Two approaches to estimating the total daily exposure: indirect (IMM) and direct (DMM) measurement methods. IMM will be covered in the next lecture; DMM involve some form of human biological monitoring (HBM). HBM supposedly provides an estimate of the internal or aggregate dose.

Prerequisite of Human Biological Monitoring HBM relies on a knowledge of the chemical’s pharmacokinetics including absorption, elimination, disposition, etc. These kinetics can be used to estimate the percent recovery of the chemical. Numerous confounding factors and considerations are involved in HBM.

Example Calculation of Biomonitoring Data As illustrated here, absorbed dose can be back-calculated from a knowledge of its urinary (or other fluid) recovery. This type of back-calculation becomes more complicated if nonbolus dose (e.g., from dermal exposure) is considered. More technical considerations and procedures for human biological monitoring have been documented.

Advantages of Human Biological Monitoring Reduces uncertainties with animal dermal absorption and with other extrapolations. Reduces uncertainty with exposure events occurring concurrently. Has the ability to determine the efficiency of various protective measures (e.g., respirator, gloves).

Limitations of Human Biological monitoring HBM per se is not route-specific; hence not quite as useful for risk mitigation. The analysis and the handling of fluid samples require special care. Although urine collection seems to be less invasive, correction for incomplete urine excretion can be difficult. Pharmacokinetics data are often from studies using animals as test subjects.

Complications With Using HBM Data The chemical’s half-life in the human body is critical to the interpretation and use of human biological monitoring (HBM) data. The exposure history of the test subject must also be considered with care. Adjustment for percent recovery may or may not be necessary depending on the patterns of repeated exposures.

Impact of the Analytical Method Used Poor sensitivity or specificity can easily under- or over-estimate the (urinary) recovery 2- to 3-fold. As spot urine sample results are more practical, there are often problems with interpreting the urinary creatinine levels that are used to gauge the correction to a 24-hour or longer urine output.

Epidemiologists’ Superior Role in HEA Human exposure assessment (HEA) is a prerequisite of environmental and occupational epidemiology. Epidemiologists deal with human test subjects more often than toxicologists do. Epidemiologists are relatively more quantitatively oriented and trained.

Overview of Next Lecture Human Exposure Assessment II In many cases, indirect measurement methods (IMM) are necessary, which along with some exposure assessment models will be covered in the next lecture. IMM each typically consists of: (1) human contact; and (2) environmental concentrations.